The Relationship between Endothelial Dysfunction and Endothelial Cell Markers in Peripheral Arterial Disease

Introduction The endothelial function plays key roles in both promoting and protecting against atherosclerotic disease. Several methods, including peripheral arterial tonometry (PAT), have been reported to be useful for investigating endothelial dysfunction. Furthermore, the level of thrombomodulin (TM) is assumed to reflect the endothelial dysfunction. In the present study, we investigated endothelial dysfunction in patients with peripheral arterial disease (PAD) by measuring their TM levels, and evaluated the correlation between TM and various parameters. Materials and Methods We measured the TM levels and performed PAT in 17 patients with PAD. We also recorded the patients’ demographic information, including comorbidities, and investigated their hemodynamic status by measuring the ankle brachial pressure index (ABI). The PAT results were used to calculate the reactive hyperemia index (RHI), which reflected the patients’ level of endothelial dysfunction. Results The RHI and ABI values and the serum level of creatinine were found to be significantly correlated with the TM level (P = 0.040, 0.041 and 0.005, respectively). After setting an RHI value of 1.67 as the cut-off, the patients with RHI values of <1.67 were found to have significantly higher TM levels (median, 20.3 U/mL) than the patients with RHI values of ≥1.67 (median, 13.7 U/mL) (P = 0.023). Conclusions The degree of endothelial dysfunction, as calculated by the TM level, might influence the prognostic value of the RHI, which is determined by PAT. The measurement of the TM level and PAT might both be useful methods of measuring endothelial dysfunction in patients with PAD.

[1]  L. Lerman,et al.  Prognostic Value of Flow‐Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events: A Systematic Review and Meta‐Analysis , 2015, Journal of the American Heart Association.

[2]  Hua-Lin Wu,et al.  Membrane-Bound Thrombomodulin Regulates Macrophage Inflammation in Abdominal Aortic Aneurysm , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[3]  L. Lerman,et al.  Secondary prevention strategy of cardiovascular disease using endothelial function testing. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[4]  A. Hagag,et al.  Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia , 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[5]  Ruichan Liu,et al.  Characterization of soluble thrombomodulin levels in patients with stage 3–5 chronic kidney disease , 2014, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[6]  O. Pachinger,et al.  Prognostic value of peripheral arterial tonometry in patients with coronary artery disease and a high cardiovascular risk profile. , 2014, Journal of atherosclerosis and thrombosis.

[7]  W. Liles,et al.  Biomarkers of endothelial activation/dysfunction in infectious diseases , 2013, Virulence.

[8]  P. Cummins,et al.  Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects , 2013, American journal of physiology. Heart and circulatory physiology.

[9]  T. van der Poll,et al.  Thrombomodulin in sepsis. , 2013, Minerva anestesiologica.

[10]  P. Poredos,et al.  Testing endothelial function and its clinical relevance. , 2013, Journal of atherosclerosis and thrombosis.

[11]  P. Aarnio,et al.  Endothelial function in a cardiovascular risk population with borderline ankle–brachial index , 2011, Vascular health and risk management.

[12]  J. Vita Endothelial Function , 2011, Circulation.

[13]  A. Blann,et al.  The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis , 2008, Journal of thrombosis and haemostasis : JTH.

[14]  D. Celermajer Reliable endothelial function testing: at our fingertips? , 2008, Circulation.

[15]  M. Wajngarten,et al.  Relationship between soluble thrombomodulin in patients with intermittent claudication and critical ischemia. , 2006, Thrombosis research.

[16]  Amir Lerman,et al.  Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. , 2004, Journal of the American College of Cardiology.

[17]  G. Brevetti,et al.  Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. , 2003, Journal of vascular surgery.

[18]  Ayan R Patel,et al.  Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. , 2003, American heart journal.

[19]  Amir Lerman,et al.  Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. , 2003, Journal of the American College of Cardiology.

[20]  E. Boerwinkle,et al.  Interaction Between Soluble Thrombomodulin and Intercellular Adhesion Molecule-1 in Predicting Risk of Coronary Heart Disease , 2003, Circulation.

[21]  C. McCollum,et al.  Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease. , 2000, Thrombosis research.

[22]  A. Blann,et al.  Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease , 1997, European journal of clinical investigation.

[23]  G. Lip,et al.  Soluble P-selectin in Atherosclerosis: A Comparison with Endothelial Cell and Platelet Markers , 1997, Thrombosis and Haemostasis.

[24]  E. Ritz,et al.  Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus. , 1996, VASA. Zeitschrift fur Gefasskrankheiten.

[25]  R. Ziegler,et al.  [Thrombomodulin is a marker of microvascular, but not for macrovascular endothelial cell damage]. , 1995, VASA. Zeitschrift fur Gefasskrankheiten.

[26]  J. Amiral,et al.  Levels of plasma thrombomodulin are increased in atheromatous arterial disease. , 1993, Thrombosis research.